Skip to main content
Top
Published in: European Radiology 11/2011

01-11-2011 | Hepatobiliary-Pancreas

Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma

Authors: Keitaro Sofue, Masakatsu Tsurusaki, Hiroyuki Tokue, Yasuaki Arai, Kazuro Sugimura

Published in: European Radiology | Issue 11/2011

Login to get access

Abstract

Objective

To compare quantitatively and qualitatively hepatocyte-phase images obtained 10 and 20 min (Images-10, and Images-20) after injection of gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid (Gd-EOB-DTPA) to detect liver metastases from colorectal carcinoma on 3.0 T MR imaging.

Methods

A total of 48 patients (26 men, 22 women; mean age, 64 years) with 88 histopathologically confirmed liver metastases underwent Gd-EOB-DTPA-enhanced MR imaging. Tumour-to-liver contrast-to-noise ratio (CNR), signal intensity gain (SIG) of liver parenchyma and overall image quality were analysed. Two radiologists independently reviewed two sets of MR images: set 1, unenhanced (T1- and T2-weighted), dynamic images and Images-10; set 2, unenhanced, dynamic and Images-20. Sensitivity and positive predictive value (PPV) to detect liver metastases, and diagnostic performance using the alternative free-response receiver operating characteristics (AFROC) method were calculated.

Results

The mean tumour-to-liver CNR, SIG of liver parenchyma and overall image quality on Images-20 were significantly higher than those on Images-10. The overall image quality of “fair to excellent” was achieved on both images in 93.8% of the patients. Sensitivity, PPV and area under the AFROC curve on set 1 were similar to set 2, including lesions <1 cm.

Conclusion

In detecting liver metastases from colorectal carcinoma, Images-10 could replace Images-20 in 3.0 T MR imaging.
Literature
1.
go back to reference Hamm B, Staks T, Muhler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792PubMed Hamm B, Staks T, Muhler A et al (1995) Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 195:785–792PubMed
2.
go back to reference Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMed Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200:59–67PubMed
3.
go back to reference Reimer P, Rummeny EJ, Ket S et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed Reimer P, Rummeny EJ, Ket S et al (1996) Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology 199:177–183PubMed
4.
go back to reference Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT–initial observations. Radiology 234:468–478PubMedCrossRef Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT–initial observations. Radiology 234:468–478PubMedCrossRef
5.
go back to reference Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 237:89–98PubMedCrossRef Bluemke DA, Sahani D, Amendola M et al (2005) Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 237:89–98PubMedCrossRef
6.
go back to reference Reimer P, Rummeny EJ, Daldrup HE et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:275–280PubMedCrossRef Reimer P, Rummeny EJ, Daldrup HE et al (1997) Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: preliminary results with dynamic MR imaging. Eur Radiol 7:275–280PubMedCrossRef
7.
go back to reference Stern W, Schick F, Kopp AF et al (2000) Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiol 41:255–262PubMedCrossRef Stern W, Schick F, Kopp AF et al (2000) Dynamic MR imaging of liver metastases with Gd-EOB-DTPA. Acta Radiol 41:255–262PubMedCrossRef
8.
9.
go back to reference Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52PubMedCrossRef Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO (2007) MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 6:43–52PubMedCrossRef
10.
go back to reference Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467PubMedCrossRef Hammerstingl R, Huppertz A, Breuer J et al (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467PubMedCrossRef
11.
go back to reference Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43:504–511PubMedCrossRef
12.
go back to reference Motosugi U, Ichikawa T, Tominaga L et al (2009) Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19:2623–2629PubMedCrossRef Motosugi U, Ichikawa T, Tominaga L et al (2009) Delay before the hepatocyte phase of Gd-EOB-DTPA-enhanced MR imaging: is it possible to shorten the examination time? Eur Radiol 19:2623–2629PubMedCrossRef
13.
go back to reference Hussain SM, Wielopolski PA, Martin DR (2005) Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging 16:325–335PubMedCrossRef Hussain SM, Wielopolski PA, Martin DR (2005) Abdominal magnetic resonance imaging at 3.0 T: problem or a promise for the future? Top Magn Reson Imaging 16:325–335PubMedCrossRef
14.
go back to reference Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186:1524–1532PubMedCrossRef Merkle EM, Dale BM (2006) Abdominal MRI at 3.0 T: the basics revisited. AJR Am J Roentgenol 186:1524–1532PubMedCrossRef
15.
go back to reference Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C (2007) Abdominal MR imaging at 3.0 T. Radiographics 27:1433–1444PubMedCrossRef Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C (2007) Abdominal MR imaging at 3.0 T. Radiographics 27:1433–1444PubMedCrossRef
16.
go back to reference Choi JY, Kim MJ, Chung YE et al (2008) Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. Radiographics 28:30CrossRef Choi JY, Kim MJ, Chung YE et al (2008) Abdominal applications of 3.0-T MR imaging: comparative review versus a 1.5-T system. Radiographics 28:30CrossRef
17.
go back to reference Tsurusaki M, Semelka RC, Zapparoli M et al (2008) Quantitative and qualitative comparison of 3.0 T and 1.5 T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 72:314–320PubMedCrossRef Tsurusaki M, Semelka RC, Zapparoli M et al (2008) Quantitative and qualitative comparison of 3.0 T and 1.5 T MR imaging of the liver in patients with diffuse parenchymal liver disease. Eur J Radiol 72:314–320PubMedCrossRef
18.
go back to reference Ramalho M, Herédia V, Tsurusaki M, Altun E, Semelka RC (2009) Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 29:869–879PubMedCrossRef Ramalho M, Herédia V, Tsurusaki M, Altun E, Semelka RC (2009) Quantitative and qualitative comparison of 1.5 and 3.0 Tesla MRI in patients with chronic liver diseases. J Magn Reson Imaging 29:869–879PubMedCrossRef
19.
go back to reference Yamashita Y, Ogata I, Urata J et al (1997) Cavenous hemangioma of the liver; pathologic correlation with dynamic CT findings. Radiology 203:121–125PubMed Yamashita Y, Ogata I, Urata J et al (1997) Cavenous hemangioma of the liver; pathologic correlation with dynamic CT findings. Radiology 203:121–125PubMed
20.
go back to reference Goshima S, Kanematsu M, Watanabe H et al (2010) Hepatic hemangioma and metastasis; differentiation with gadoxetate disodium-enhanced MRI with 3 T system. AJR Am J Roentogenol 195:941–946CrossRef Goshima S, Kanematsu M, Watanabe H et al (2010) Hepatic hemangioma and metastasis; differentiation with gadoxetate disodium-enhanced MRI with 3 T system. AJR Am J Roentogenol 195:941–946CrossRef
21.
go back to reference Semelka RC, Hussain SM, Marcos HB, Woosley JT (2000) Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings - initial observations. Radiology 215:89–94PubMed Semelka RC, Hussain SM, Marcos HB, Woosley JT (2000) Perilesional enhancement of hepatic metastases: correlation between MR imaging and histopathologic findings - initial observations. Radiology 215:89–94PubMed
22.
go back to reference Nasu K, Kuroki Y, Nawano S et al (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122–130PubMedCrossRef Nasu K, Kuroki Y, Nawano S et al (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122–130PubMedCrossRef
23.
go back to reference Shimada K, Isoda H, Hirokawa Y et al (2010) Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 20:2690–2698PubMedCrossRef Shimada K, Isoda H, Hirokawa Y et al (2010) Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 20:2690–2698PubMedCrossRef
Metadata
Title
Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma
Authors
Keitaro Sofue
Masakatsu Tsurusaki
Hiroyuki Tokue
Yasuaki Arai
Kazuro Sugimura
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
European Radiology / Issue 11/2011
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-011-2197-0

Other articles of this Issue 11/2011

European Radiology 11/2011 Go to the issue